©Dr A. Dossou, Centre de Dépistage et de traitement de l’Ulcère de Buruli, 2015
30 September 2015 | Geneva –– It took years to develop – but field trials now confirm that a rapid diagnostic test can detect Buruli ulcer (Mycobacterium ulcerans disease) in a patient in moderately equipped district-level health facilities without the need for sophisticated laboratory equipment.
The test produces results within one hour – a great achievement for the early diagnosis of this devastating skin disease.
Geneva | 19 February 2015
New WHO report urges governments to increase investment to tackle these diseases of poverty
The third report of the World Health Organization (WHO) on neglected tropical diseases urges affected countries to enhance their domestic investments in order to sustainably address social and health inequities. Creating conditions to generate the investments needed to overcome these diseases – which blind, disfigure, disable and kill – will provide an essential package of interventions to more than 1.5 billion people worldwide.
27 May 2013 | Geneva
Member States call for more focus on the growing threat and spread of dengue
The World Health Assembly today adopted resolution WHA66.12 on all 17 neglected tropical diseases.
Many countries called on WHO to focus more on the growing threat and expansion of dengue and support the scale-up of vector control activities.
Representatives from 32 countries and six speakers from nongovernmental organizations took part in the deliberations.
New phase in fight against NTDs heralds universal access to health interventions for world’s poorest
Sustained commitment key to reaching eradication and elimination targets by 2020
16 January 2013 | Geneva
The World Health Organization’s second report on neglected tropical diseases published today highlights unprecedented progress during the past two years.
Renewed momentum has shifted the world closer to eliminating many of these conditions that take their greatest toll among the poor, thanks to a new global strategy, a regular supply of quality-assured, cost-effective medicines and support from global partners. | More